Find uplifting stories about heroes, innovations, and solutions
47 results for "treatment options"
Multiple research teams discovered that aggressive lung cancer cells form actual connections with brain neurons, and drugs that block these connections slow tumor growth in mice. The breakthrough could lead to new treatment options for one of the deadliest cancers.
Children born with epidermolysis bullosa, a painful genetic disorder causing skin to blister at the slightest touch, now have real treatment options for the first time. Three new FDA-approved therapies are healing wounds that doctors could only bandage before.
A new targeted therapy for a rare form of lung cancer just earned priority review from the FDA, potentially offering hope to thousands of patients who currently have limited treatment options. The drug specifically targets HER2 mutations found in about 2-4% of lung cancer cases.
A breakthrough drug for pancreatic cancer has stunned researchers by controlling disease in 90% of patients who had already tried chemotherapy. The daily pill targets gene mutations found in nearly all pancreatic cancers, offering hope where treatment options have been scarce.
The FDA just approved two new treatment combinations for cancer patients who've run out of options. These approvals bring fresh hope to people battling mantle cell lymphoma.
Researchers discovered that pancreatic cancer cells depend on inflammation from damaged mitochondria to survive, and blocking this process kills tumors. The breakthrough could finally offer new treatment options for one of the deadliest cancers.
For people with Crohn's disease and ulcerative colitis who've run out of treatment options, two new studies reveal a promising combination therapy that works better than single medications. The breakthrough could help millions who haven't responded to any previous treatments.
After surprising companies with a rejection in January, the FDA has agreed that existing trial data for a rare blood cancer therapy is sufficient for approval review. The agency's reversal gives new hope to patients with limited treatment options.
A groundbreaking combination therapy is helping people with inflammatory bowel disease who've run out of treatment options. Clinical trials show remission rates jumping by up to 40 percentage points for the hardest-to-treat patients.
A groundbreaking trial found that semaglutide, the popular weight loss drug, significantly reduced alcohol cravings and heavy drinking days in people battling both obesity and alcohol addiction. The discovery could transform treatment options for millions worldwide struggling with alcohol use disorder.
Scientists at the University of Trento developed the first gene therapy for 10% of cystic fibrosis patients who had no treatment options until now. The breakthrough could lead to a permanent cure instead of lifelong drug dependence.
Early research suggests GLP-1 drugs like Ozempic might help treat endometriosis, offering hope to millions who struggle with limited treatment options. Women are already reporting symptom improvements on social media.
The Justice Department moved state-licensed medical marijuana from Schedule I to Schedule III, opening doors for research and expanded treatment options. Veterans and patients with mental health conditions could benefit most from the policy shift.
Women with a hard-to-treat form of ovarian cancer now have access to a diagnostic test that could connect them with life-extending treatment options. The nationwide rollout marks a breakthrough for patients who previously faced limited hope.
Bladder cancer patients now have more treatment options than ever before, thanks to several new therapies approved in recent years. Doctors are working closely with patients to find the best approach for each person's unique situation. #
A mother is running the London Marathon to fund research for gene therapies that could save her daughter from kidney failure. Her eight-year-old was diagnosed with a rare, incurable form of nephrotic syndrome that currently has no treatment options.
Children with eosinophilic esophagitis now have more treatment options than ever, including a convenient at-home injection and monitoring tools that don't require sedation. These advances are making life easier for families managing this chronic digestive condition.
A breakthrough pill for pancreatic cancer almost doubled survival time and cut death risk by 60% in a major trial. Revolution Medicines plans to seek fast-track FDA approval for patients who desperately need new treatment options.
Scientists at Oregon Health & Science University just cracked a puzzle that's stumped cancer researchers for years: why pancreatic cancer fights off immunotherapy. The discovery could finally give patients new treatment options.
Researchers at MD Anderson Cancer Center discovered a protein called DPY30 that helps pancreatic tumors hide from the immune system. Blocking this protein could make stubborn tumors respond to immunotherapy, offering fresh hope for patients with limited treatment options.
Showing 20 of 47